IMCD Stock

IMCD Equity

The The Equity of IMCD (IMCD.AS) as of Aug 7, 2026 is 2.04 B EUR. In the previous year, The Equity was 2.21 B EUR — a change of -7.81% (lower).

Equity

2.04 BEUR

YoY

-7.81%

Last updated:

In 2026, IMCD's equity was 2.04 B EUR, a -7.81% increase from the 2.21 B EUR equity in the previous year.

Access this data via the Eulerpool API

IMCD Stock analysis

What does IMCD do? IMCD NV is a leading global distributor of specialty chemicals and food ingredients with over 100 years of experience in the industry. The company, founded in 1995, is headquartered in Rotterdam, Netherlands, and operates business in over 50 countries worldwide. History: IMCD was founded as an intermediary for pharmaceuticals and specialty chemicals, initially under the name Internatio-Müller. The company grew rapidly and expanded its product offering. In 1995, the company was renamed IMCD and began to further diversify in various areas, including Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Business model: IMCD offers a wide range of specialty and raw materials from leading manufacturers. The company provides customized services, including consultation, logistics, and technical support. They work closely with their customers and suppliers to support product development and application solutions. Segments: IMCD is divided into five main areas: Pharmaceuticals, Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Pharmaceuticals: IMCD offers a wide range of active ingredients, excipients, and granulates for the pharmaceutical industry. This includes API's (Active Pharmaceutical Ingredients), excipients, additives, and formulations. The products are offered for most areas of human and veterinary pharmacy. Coatings & Construction: IMCD offers solutions for the areas of paints, coatings, and construction. The company has extensive expertise in the formulation of coatings, paints, and coatings, as well as application technology and software-based color measurements. Life Sciences: IMCD offers a comprehensive range of specialty chemicals and raw materials for biotechnology, diagnostics, and analytics. The products are suitable for applications in medical diagnostics, biopharmaceutical production, and medical research. Personal Care: IMCD is a major supplier of raw materials and formulations for fragrant cosmetics, skincare, haircare, oral care, sun protection, and soaps. Food & Nutrition: IMCD offers a wide range of raw materials, ingredients, and additives for the food and beverage industry. This includes various ingredients such as emulsifiers, stabilizers, acid regulators, dyes, sweeteners, flavors, and dietary supplements. Products: IMCD offers a wide range of products used in various industries. In addition to the mentioned categories, IMCD also distributes solutions for the industrial sector, construction chemistry, environment, and energy. Their products include specialty chemicals, raw materials, formulations, and additives for all application areas, as well as technical manufacturing process and application technology, as well as laboratory and test reports. Some of the most well-known brands in their portfolio include Evonik, Huntsman, DSM, Solvay, and L'Oréal. In summary, IMCD is an important distributor and partner for numerous companies worldwide. With a diverse product portfolio and technical know-how, they support their customers in the development and production of innovative solutions. IMCD is one of the most popular companies on Eulerpool.

Equity Details

Analyzing IMCD's Equity

IMCD's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding IMCD's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating IMCD's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

IMCD's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in IMCD’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about IMCD stock

The Equity of IMCD is 2.04 B EUR in 2026.

The Equity of IMCD changed from 2.21 B EUR to 2.04 B EUR, representing a -7.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity IMCD since 2006 – with annual values, charts, and detailed analysis.

The Equity's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's IMCD historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — IMCD

All Key Metrics — IMCD